J. Colella

Long‐term outcome after allogeneic stem‐cell transplantation with reduced‐intensity conditioning in patients with multiple myeloma

R. Bouabdallah, D. Blaise, D. Coso, 2013, American journal of hematology/oncology.

Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity

D. Olive, F. Mallet, R. Sweet, 2003, Leukemia.

Brentuximab vedotin and bendamustine as first-line treatment of Hodgkin lymphoma in the elderly (HALO Trial).

A. Rossi, R. Schiappa, A. Gallamini, 2020 .